Pfizer 5% Dextrose Injection Recall: Potential Leaks Risk
Pfizer recalls 50mL 5% Dextrose Injection units with potential leak risk. This sterile injection product may cause contamination if the bag leaks.
Stop using this now
Lack of sterility assurance: bag has the potential to leak.
Contact the company
What happened, in plain English
Pfizer is recalling 50mL 5% Dextrose Injection units that could leak, potentially causing contamination. This is a serious issue for medical use since leaks could lead to infections. Read more at govinfonow.com/recall/35504-pfizer-5-dextrose-injection-recall-potential-leaks-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/35504-pfizer-5-dextrose-injection-recall-potential-leaks-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0265-2022
Cite this page
“Pfizer 5% Dextrose Injection Recall: Potential Leaks Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35504-pfizer-5-dextrose-injection-recall-potential-leaks-risk. Based on FDA recall #D-0265-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0265-2022%22&limit=1).
Why it’s dangerous
The bag may leak, which could lead to contamination of the solution. This poses a risk of infection or improper medication delivery during medical procedures.
Who’s affected
Healthcare professionals and patients who have received this specific 50mL dextrose injection unit. Those using it for medical treatments are most at risk.
How to tell if you have this one
Check for the 50mL 5% Dextrose Injection, USP, ADD-Vantage Unit with NDC 0409-7100-68 or 0409-7100-66. The lot number 4923608 with expiration date May 2022.
- Brand
Pfizer- Category
Drug
What to do — step by step
Stop Using Now
Immediately stop using the recalled 50mL 5% Dextrose Injection units as they may leak.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0265-2022 (November 30, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0265-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.